Stay updated on Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    New navigation/help items were added: How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment, and the revision tag Revision: v3.6.0. The navigation item Intervention / Treatment was removed.
    Difference
    0.5%
    Check dated 2026-06-13T17:53:17.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A new page revision v3.5.5 was published, replacing the previous v3.5.4. This reflects a minor update to the page's metadata or formatting rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-06-06T14:21:36.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    A new revision tag v3.5.4 was added and the previous tag v3.5.3 was removed, updating the page's version label in the site metadata.
    Difference
    0.1%
    Check dated 2026-05-15T22:47:35.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page footer revision/version was incremented from **v3.5.2** to **v3.5.3**, reflecting a minor technical update to the site presentation rather than a change to the clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-24T05:45:49.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:28:06.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:56:33.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial page.